A new PPARα/γ co-agonist for the treatment of dyslipidemia

被引：0
|
作者：
Clay, C [1 ]
Tigon, X [1 ]
Ding, S [1 ]
Braileanu, G [1 ]
Hansen, B [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] A new PPARα/γ co-agonist for the treatment of dyslipidemia
    Clay, CE
    Tigno, XT
    Ding, SY
    Braileanu, GT
    Hansen, BC
    FASEB JOURNAL, 2004, 18 (05): : A995 - A995
  • [2] Structure-based design and synthesis of fluorescent PPARα/δ co-agonist and its application as a probe for fluorescent polarization assay of PPARδ ligands
    Araya, Yoko
    Kasuga, Jun-ichi
    Toyota, Kenji
    Hirakawa, Yuko
    Oyama, Takuji
    Makishima, Makoto
    Morikawa, Kosuke
    Hashimoto, Yuichi
    Miayachi, Hiroyuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (09) : 1357 - 1359
  • [3] Co-agonist therapeutics come of age for obesity
    Tan, Tricia M. -M.
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (02) : 66 - 67
  • [4] Co-agonist therapeutics come of age for obesity
    Tricia M.-M. Tan
    Nature Reviews Endocrinology, 2023, 19 : 66 - 67
  • [5] A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
    Day, Jonathan W.
    Ottaway, Nickki
    Patterson, James T.
    Gelfanov, Vasily
    Smiley, David
    Gidda, Jas
    Findeisen, Hannes
    Bruemmer, Dennis
    Drucker, Daniel J.
    Chaudhary, Nilika
    Holland, Jenna
    Hembree, Jazzminn
    Abplanalp, William
    Grant, Erin
    Ruehl, Jennifer
    Wilson, Hilary
    Kirchner, Henriette
    Lockie, Sarah Haas
    Hofmann, Susanna
    Woods, Stephen C.
    Nogueiras, Ruben
    Pfluger, Paul T.
    Perez-Tilve, Diego
    DiMarchi, Richard
    Tschoep, Matthias H.
    NATURE CHEMICAL BIOLOGY, 2009, 5 (10) : 749 - 757
  • [6] A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
    Jonathan W Day
    Nickki Ottaway
    James T Patterson
    Vasily Gelfanov
    David Smiley
    Jas Gidda
    Hannes Findeisen
    Dennis Bruemmer
    Daniel J Drucker
    Nilika Chaudhary
    Jenna Holland
    Jazzminn Hembree
    William Abplanalp
    Erin Grant
    Jennifer Ruehl
    Hilary Wilson
    Henriette Kirchner
    Sarah Haas Lockie
    Susanna Hofmann
    Stephen C Woods
    Ruben Nogueiras
    Paul T Pfluger
    Diego Perez-Tilve
    Richard DiMarchi
    Matthias H Tschöp
    Nature Chemical Biology, 2009, 5 : 749 - 757
  • [7] Dissection of hippocampal NMDA receptor co-agonist signalling assisted by new optical sensors
    Henneberger, Christian
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 22 - 22
  • [8] Comparative Transcriptional Network Modeling of Three PPARα/γ Co-Agonist Treatments Reveals Unique Metabolic Signatures Despite Similar Core PPAR Signaling
    Blander, Gil
    Maerz-Weiss, Pia
    Catlett, Natalie
    Steiner, Guido
    Wong, Ben
    Wright, Matthew
    Laifenfeld, Daphna
    Matthews, Andrea
    Bobadilla, Maria
    Mizrahi, Jacques
    Haefliger, Carolina
    Edgar, Alan
    Plutzky, Jorge
    DIABETES, 2009, 58 : A295 - A295
  • [9] Design and discovery of a potent, selective and orally active PPAR α agonist for the treatment of dyslipidemia.
    Sahoo, SP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U201 - U201
  • [10] Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disorders
    Patel, Harilal
    Giri, Poonam
    Patel, Prakash
    Singh, Sanjay
    Gupta, Laxmikant
    Patel, Urvesh
    Modi, Nirav
    Shah, Kalpesh
    Jain, Mukul R.
    Srinivas, Nuggehally R.
    Patel, Pankaj
    XENOBIOTICA, 2018, 48 (12) : 1268 - 1277
12345